## GE: GE Aerospace - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -3.8% below STRENGTH zone (3.0-6.0%); PEG 5.84 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($273.88)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Diverging Signals Emerge for General Electric Stock**
- Source: Ad-hoc-news.de | 20251201T075504 | Neutral | Relevance: 98%
- General Electric is experiencing contrasting signals, with significant capital expenditure in Europe indicating long-term operational strength, while institutional investors are reducing stakes and an insider has sold shares. Despite robust quarterly earnings and reaffirmed 2025 EPS guidance, quantitative valuation models suggest the stock is trading at a premium. The core debate for investors centers on whether GE's operational improvements can justify its elevated valuation.

**2. General Electric shareholders – who owns the most GE stock?**
- Source: Capital.com | 20251201T213654 | Neutral | Relevance: 98%
- This article details the ownership structure of General Electric's three independent entities—GE Aerospace, GE Vernova, and GE HealthCare Technologies—following its three-way split. It highlights how institutional investors, particularly mutual funds and ETFs, hold the majority of shares across all three companies, with Capital Research and Management Company, Vanguard, and BlackRock being prominent large shareholders. The article also touches on insider ownership, with H. Lawrence Culp Jr. being a key insider shareholder.

**3. General Electric shareholders – who owns the most GE stock?**
- Source: Capital.com | 20251201T222128 | Somewhat-Bullish | Relevance: 98%
- This article details the ownership structure of General Electric's three independent entities—GE Aerospace, GE Vernova, and GE HealthCare Technologies—after its significant 2024 restructuring. It highlights that institutional investors, particularly mutual funds and ETFs like Vanguard and BlackRock, hold the majority stakes across all three companies, with retail investors making up a meaningful minority. The article also touches upon insider ownership and advises potential investors to conduct thorough research before trading.

**4. A Fresh Look at General Electric's Valuation After Strategic Aerospace Deal With Saudia Group**
- Source: Simply Wall Street | 20251202T005941 | Bullish | Relevance: 98%
- General Electric (GE) has secured a multi-year deal with Saudia Group for GEnx-1B engines and maintenance services, boosting its aerospace strategy. Despite a recent dip, GE's share price has seen significant gains year-to-date, suggesting market confidence in its transformation. While analysts consider GE undervalued with a target of $339, a DCF model presents a more cautious outlook, raising questions about potential overvaluation.

**5. GE Aerospace Stock on December 1, 2025: Price, Fresh News, and 2026 Forecasts**
- Source: ts2.tech | 20251201T195221 | Bullish | Relevance: 98%
- GE Aerospace stock traded at $290.58 on December 1, 2025, down 2.6% on the day but still significantly up over the past year, reflecting its strong performance as an aerospace and defense pure-play. The article details recent company news, including a £19 million investment in its Wales MRO hub, institutional investor activity, recognition as a top defense stock, and resolution of a legal overhang related to fraudulent parts documentation. Despite a premium valuation, analysts remain largely bullish, driven by robust Q3 2025 results and positive 2025 guidance, but caution on valuation risks remains.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Susquehanna | $350 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Susquehanna | init | Positive |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($10.08M) |
| Sells | 2 ($2.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.7% (+0.1%)
- Blackrock Inc.: 8.3% (+5.3%)
- FMR, LLC: 5.2% (-9.1%)
- TCI Fund Management : 4.5% (0.0%)
- Capital Internationa: 4.2% (-5.8%)

### Key Risks

1. Valuation stretched: PEG 5.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.84 signals overvaluation risk, limited margin of safety. Forward P/E 40.3x stretched relative to 16% growth. Quality metrics strong (ROE 42%, margin 18%). Balance sheet: $2.2B free cash flow. Insider buying signal ($10.1M), management confidence. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $300.7B |
| Beta | 1.41 |
| 52W Range | $159.36 - $316.67 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.84 |
| Forward P/E | 40.3 |
| Current P/E | 46.5 |
| YoY Growth | 15.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 weakening modestly (-1.0% over 5 days). Below STRENGTH zone by 6.8pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.15x) but short-term weakness (below SMA20). MACD histogram bearish (-1.38), momentum weakening. RSI neutral at 41.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.83% (CS: 13) | Weak |
| RSI_14 | 40.6 | Neutral |
| MACD Histogram | -1.38 | Bearish |
| vs SMA20 | 0.965x | Below |
| vs SMA50 | 0.960x | Below |
| vs SMA200 | 1.148x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $289.32
- **Stop Loss:** $273.88 (5.3% risk)
- **Target:** $304.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 32
- **Position Value:** $9,258.24
- **Portfolio %:** 9.26%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-22 (Est: $1.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.47 | $1.66 | +13.0% |
| 2025Q2 | $1.43 | $1.66 | +16.0% |
| 2025Q1 | $1.27 | $1.49 | +17.5% |
| 2024Q4 | $1.04 | $1.32 | +26.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*